Anti-Entamoeba (ENTH-0504)
Anti-Entamoeba (ENTH-0504)
Product No.: E164
- -
- -
Clone ENTH-0504 Target Entamoeba Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG2b Applications ELISA , Lateral Flow |
- -
- -
Antibody DetailsProduct DetailsReactivity Species E. dispar ⋅ E. histolytica Host Species Mouse Product Concentration ≥1.0 mg/ml Purity ≥90% Formulation Formulated in 0.01 M phosphate buffered saline, pH 7.2 and contains 0.1% sodium azide. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation This monoclonal antibody is purified by protein A chromatography or sequential differential precipitations. Storage and Handling This purified antibody is stable when stored at 2-8°C. Do not freeze. Regulatory Status Research Use Only Country of Origin USA Shipping 2-8°C Wet Ice Applications and Recommended Usage? Quality Tested by Leinco ELISA: 1:20-1:200 Additional Applications Reported In Literature ? Lateral Flow Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-Entamoeba (Clone ENTH-0504) is specific for E. histolytica and E. dispar Matched Pair Best ELISA pair (capture/detection), ENTH-0504/ENTH-7620 Background Entamoeba histolytica is a pathogenic amoeba that causes amebiasis, a significant intestinal and extra-intestinal infection in humans. It is a single-celled protozoan parasite belonging to the Entamoeba genus. Infection occurs through the ingestion of cysts, the dormant and infective stage of the parasite, found in contaminated food or water. Once inside the human host, the cysts release trophozoites, the active form of the parasite, which colonize the large intestine and can cause diarrhea, abdominal pain, and other gastrointestinal symptoms. In some cases, E. histolytica can penetrate the intestinal wall, leading to the formation of liver abscesses and extra-intestinal manifestations. The disease is especially prevalent in areas with poor sanitation and limited access to clean water. Proper sanitation, personal hygiene, and water purification are crucial in preventing the transmission of E. histolytica and reducing the burden of amebiasis worldwide. Antigen DetailsResearch Area Category B Pathogens . Infectious Disease . Matched Pair . Parasite . IVD Raw Material References & Citations1. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) Technical Protocols |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.